Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.8 USD | -2.02% | -14.26% | +32.37% |
09/05 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
07/05 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.37% | 479.95Cr | |
+10.83% | 12TCr | |
+11.68% | 11TCr | |
-6.39% | 2.47TCr | |
-2.33% | 2.2TCr | |
-6.03% | 1.93TCr | |
-13.47% | 1.76TCr | |
-40.50% | 1.73TCr | |
+6.37% | 1.4TCr | |
+31.49% | 1.21TCr |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- Nantkwest : Reports Positive Interim Data on Survival Rates from Pivotal Pancreatic Cancer Trials; Shares Hit New 52-Week High